Why drug repurposing strategies reduce risk

This week's Fierce Biotech is brought to you by Thermo Fisher Scientific.

Trouble viewing? Click here.

WHITEPAPER
Drug repurposing trends and strategic approaches for shortening timelines

WP-STE-Drug-Repurposing-Trends-and-Strategic-Approaches

Drug repurposing constitutes anywhere from 10% to 50% of the current R&D spending and is a determining factor in the life cycle management of pharmaceutical products. Repurposing drug candidates are known for their safety, cost savings, and commercial benefits. Download this white paper to learn more about:

The drug repurposing development pathway
Low-risk and cost-effective strategies
Case study examples on bringing molecules to market faster

Download Whitepaper

Thermo Fisher Scientific, 4815 Emperor Blvd., Durham, NC 27703-8470, USA | +1 919-226-3200
thermofisher.com/patheon | pharmaservices@thermofisher.com | Privacy Information Center

© 2021 Thermo Fisher Scientific Inc. All Rights Reserved.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.

You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017